Monitor regulatory approval process and any permanent financing announcements (bond or equity issuance) that could affect leverage. The earnout tied to 2028 performance targets provides a catalyst for post-close integration updates.
Price Chart
Executive Summary
STERIS plc, through its subsidiary STERIS Corporation, has agreed to acquire Xodus Medical, Inc., a specialty surgical products business, for $2.1 billion in cash at closing, with up to $150 million in additional earnout consideration based on 2028 performance targets. The acquisition is expected to close by December 31, 2026, financed primarily with debt, and STERIS has secured a $2.0 billion bridge facility from JPMorgan and Goldman Sachs to support the transaction.
Key Financial Metrics
Key Facts
- STERIS Corporation to acquire all equity interests of Xodus Medical, Inc. for $2.1 billion in cash at closing.
- Additional potential earnout consideration of up to $150 million based on 2028 performance targets.
- Acquisition expected to close by December 31, 2026, subject to customary closing conditions and regulatory approvals.
- Bridge financing commitment of up to $2.0 billion secured from JPMorgan Chase Bank and Goldman Sachs Bank USA.
- Acquisition to be financed primarily with debt.
Financial Impact
$2.1 billion cash acquisition price plus up to $150 million earnout; $2.0 billion bridge facility arranged.
Risk Factors
- Regulatory approvals may not be obtained or may impose conditions that delay or prevent closing.
- Integration risks and potential failure to achieve earnout targets or cost synergies.
- Increased leverage from debt financing could pressure credit metrics and future borrowing costs.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-420487 |
| Document: 0001193125-26-420487-index-headers.html | 0001193125-26-420487 |
| Document: 0001193125-26-420487-index.html | 0001193125-26-420487 |
| Document: 0001193125-26-420487.txt | 0001193125-26-420487 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Press Release | $221.48 | awaiting T+5 | — | $230.12 (+3.90%) |
Oct 13, 2026 13d ago | 8-K | $217.26 $221.48 | ▲ +1.94% | ▲ +1.49% | $230.12 (+5.92%) |
Jul 27, 2026 13w ago | Press Release | $230.34 $232.64 | ▲ +1.00% | ▼ −1.27% | $230.12 (−0.10%) |
Jun 15, 2026 19w ago | 144 | $206.51 $203.21 | ▼ −1.60% | ▲ +0.63% | $230.12 (+11.43%) |
Jun 11, 2026 19w ago | DEFA14A | $207.56 $202.61 | ▼ −2.38% | ▼ −3.06% | $230.12 (+10.87%) |
Jun 8, 2026 20w ago | Insider Cluster | $212.88 $205.93 | ▼ −3.26% | ▼ −5.68% | $230.12 (+8.10%) |
Jun 5, 2026 20w ago | 144 | $210.03 $205.93 | ▼ −1.95% | ▼ −4.06% | $230.12 (+9.57%) |
Jun 4, 2026 20w ago | 144 | $212.35 $207.56 | ▼ −2.26% | ▼ −2.83% | $230.12 (+8.37%) |
May 11, 2026 24w ago | 8-K | $210.23 $212.87 | ▼ −1.26% | ▼ −1.18% | $230.12 (−9.46%) |
May 11, 2026 24w ago | Press Release | $210.23 $212.87 | ▲ +1.26% | ▲ +1.18% | $230.12 (+9.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers